Tag: leukemia

1. Patients with hematological malignancies were found to be at an increased risk of COVID-19 and were more likely to ...

1. Patients with relapsed or remitting chronic lymphocytic leukemia (CLL) treated with venetoclax-rituximab had a greater 2-year progression-free survival rate compared ...

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia BCL2 is an anti-apoptotic protein that allows chronic lymphocytic leukemia cells ...

  1. The compound ICG-001 sensitized chemoresistant leukemia-initiating cells (LICs) to Imatinib (IM) and inhibited their ability to survive and ...

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL) is a ...

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia BRAF V600E has been identified as the genetic lesion responsible for ...

1. Mice harboring tumors with translocations of the mixed lineage leukemia (MLL) gene showed decreased tumor size and increased survival ...

Originally published by Harvard Health. What Is It? Acute myeloid leukemia (AML) is a type of leukemia. It is also called ...

In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Goal-Directed ...

1. Ibrutinib was superior to ofatumumab in a head-to-head trial in patients who have failed initial therapy for chronic lymphoid ...